Skip to main content
Top
Published in: Endocrine 1/2014

01-05-2014 | Meta-Analysis

Clinical characteristics as predictors of malignancy in patients with indeterminate thyroid cytology: a meta-analysis

Authors: Pierpaolo Trimboli, Giorgio Treglia, Leo Guidobaldi, Enrico Saggiorato, Giuseppe Nigri, Anna Crescenzi, Francesco Romanelli, Fabio Orlandi, Stefano Valabrega, Ramin Sadeghi, Luca Giovanella

Published in: Endocrine | Issue 1/2014

Login to get access

Abstract

Indeterminate thyroid nodules (ITN) constitute the gray zone of thyroid fine-needle aspiration cytology (FNAC). About 70–80 % of ITN are later diagnosed as benign; therefore, it is very important to identify the predictors of malignancy. Aim of the study was to summarize published data about clinical risk factors for malignancy in patients with ITN and thereby provide more robust estimates of the effect of these risk factors. Sources comprised studies published through December 2012. Original articles that investigated clinical parameters as potential predictors of malignancy in ITN were identified. Two authors performed the data extraction independently. A meta-analysis of 19 relevant studies was conducted that included 3,494 patients with ITN according to FNAC. The pooled prevalence of malignancy was 28 % (95 % CI 23–33), 26 % in females and 34 % in males. The pooled OR was 1.51 (95 % CI 1.2–1.83) for males and 0.68 (95 % CI 0.53–0.88) for females. Regarding the nodule’s size, the pooled OR was 2.10 (95 % CI 1.26–3.50) for nodules >4 cm in diameter. Analysis of the patient age as a risk factor was not feasible because of marked difference found between the studies. In patients with indeterminate thyroid nodules diagnosed at FNAC, the pooled rate of malignancy from 19 studies was 28 %. Patients that are male and have ITN greater than 4 cm in diameter should be considered at higher risk of cancer.
Literature
1.
go back to reference H. Gharib, E. Papini, R. Paschke, D.S. Duick, R. Valcavi, L. Hegedüs, P. Vitti, AACE/AME/ETA task force on thyroid nodules: American association of clinical endocrinologists, associazione medici endocrinologi, and european thyroid association medical guidelines for clinical practice for the diagnosis and management of thyroid nodules. Endocr. Pract. 16, 1–43 (2010)PubMedCrossRef H. Gharib, E. Papini, R. Paschke, D.S. Duick, R. Valcavi, L. Hegedüs, P. Vitti, AACE/AME/ETA task force on thyroid nodules: American association of clinical endocrinologists, associazione medici endocrinologi, and european thyroid association medical guidelines for clinical practice for the diagnosis and management of thyroid nodules. Endocr. Pract. 16, 1–43 (2010)PubMedCrossRef
2.
go back to reference Guidelines for the management of thyroid cancer (second edition) Royal College of Physicians of London. The Lavenham Press, Suffolk 2007 Guidelines for the management of thyroid cancer (second edition) Royal College of Physicians of London. The Lavenham Press, Suffolk 2007
3.
go back to reference Z.W. Baloch, M.J. Sack, G.H. Yu, V.A. Livolsi, P.K. Gupta, Fine-needle aspiration of thyroid: an institutional experience. Thyroid. 8, 565–569 (1998)PubMedCrossRef Z.W. Baloch, M.J. Sack, G.H. Yu, V.A. Livolsi, P.K. Gupta, Fine-needle aspiration of thyroid: an institutional experience. Thyroid. 8, 565–569 (1998)PubMedCrossRef
4.
go back to reference E.S. Cibas, S.Z. Ali, The bethesda system for reporting thyroid cytopathology. Thyroid. 19, 1159–1165 (2009)PubMedCrossRef E.S. Cibas, S.Z. Ali, The bethesda system for reporting thyroid cytopathology. Thyroid. 19, 1159–1165 (2009)PubMedCrossRef
5.
go back to reference A. Bartolazzi, F. Orlandi, E. Saggiorato, M. Volante, F. Arecco, R. Rossetto, N. Palestini, E. Ghigo, M. Papotti, G. Bussolati, M.P. Martegani, F. Pantellini, A. Carpi, M.R. Giovagnoli, S. Monti, V. Toscano, S. Sciacchitano, G.M. Pennelli, C. Mian, M.R. Pelizzo, M. Rugge, G. Troncone, L. Palombini, G. Chiappetta, G. Botti, A. Vecchione, R. Bellocco, ItalianThyroidCancerStudy Group (ITCSG): galectin-3-expression analysis in the surgicalselection of follicularthyroidnoduleswith indeterminate fine-needle aspiration cytology: a prospectivemulticentrestudy. Lancet. Oncol. 9, 543–549 (2008)PubMedCrossRef A. Bartolazzi, F. Orlandi, E. Saggiorato, M. Volante, F. Arecco, R. Rossetto, N. Palestini, E. Ghigo, M. Papotti, G. Bussolati, M.P. Martegani, F. Pantellini, A. Carpi, M.R. Giovagnoli, S. Monti, V. Toscano, S. Sciacchitano, G.M. Pennelli, C. Mian, M.R. Pelizzo, M. Rugge, G. Troncone, L. Palombini, G. Chiappetta, G. Botti, A. Vecchione, R. Bellocco, ItalianThyroidCancerStudy Group (ITCSG): galectin-3-expression analysis in the surgicalselection of follicularthyroidnoduleswith indeterminate fine-needle aspiration cytology: a prospectivemulticentrestudy. Lancet. Oncol. 9, 543–549 (2008)PubMedCrossRef
6.
go back to reference P. Trimboli, E. Condorelli, A. Catania, S. Sorrenti, Clinical and ultrasound parameters in the approach to thyroid nodules cytologically classified as indeterminate neoplasm. Diagn. Cytopathol. 37, 783–785 (2009)PubMedCrossRef P. Trimboli, E. Condorelli, A. Catania, S. Sorrenti, Clinical and ultrasound parameters in the approach to thyroid nodules cytologically classified as indeterminate neoplasm. Diagn. Cytopathol. 37, 783–785 (2009)PubMedCrossRef
7.
go back to reference T. Rago, G. Di Coscio, C. Ugolini, M. Scutari, F. Basolo, F. Latrofa, R. Romani, P. Berti, L. Grasso, L.E. Braverman, A. Pinchera, P. Vitti, Clinical features of thyroid autoimmunity are associated with thyroiditis on histology and are not predictive of malignancy in 570 patients with indeterminate nodules on cytology who had a thyroidectomy. Clin. Endocrinol. (Oxf) 67, 363–369 (2007)CrossRef T. Rago, G. Di Coscio, C. Ugolini, M. Scutari, F. Basolo, F. Latrofa, R. Romani, P. Berti, L. Grasso, L.E. Braverman, A. Pinchera, P. Vitti, Clinical features of thyroid autoimmunity are associated with thyroiditis on histology and are not predictive of malignancy in 570 patients with indeterminate nodules on cytology who had a thyroidectomy. Clin. Endocrinol. (Oxf) 67, 363–369 (2007)CrossRef
8.
go back to reference N.L. Davis, M. Gordon, E. Germann, R.E. Robins, G.I. McGregor, Clinical parameters predictive of malignancy of thyroid follicular neoplasms. Am. J. Surg. 161, 567–569 (1991)PubMedCrossRef N.L. Davis, M. Gordon, E. Germann, R.E. Robins, G.I. McGregor, Clinical parameters predictive of malignancy of thyroid follicular neoplasms. Am. J. Surg. 161, 567–569 (1991)PubMedCrossRef
9.
go back to reference H. Chen, T.L. Nicol, M.A. Zeiger, W.C. Dooley, P.W. Ladenson, D.S. Cooper, M. Ringel, S. Parkerson, M. Allo, R. Udelsman, Hürthle cell neoplasms of the thyroid: are there factors predictive of malignancy? Ann. Surg. 227, 542–546 (1998)PubMedCrossRefPubMedCentral H. Chen, T.L. Nicol, M.A. Zeiger, W.C. Dooley, P.W. Ladenson, D.S. Cooper, M. Ringel, S. Parkerson, M. Allo, R. Udelsman, Hürthle cell neoplasms of the thyroid: are there factors predictive of malignancy? Ann. Surg. 227, 542–546 (1998)PubMedCrossRefPubMedCentral
10.
go back to reference R.M. Tuttle, H. Lemar, H.B. Burch, Clinical features associated with an increased risk of thyroid malignancy in patients with follicular neoplasia by fine-needle aspiration. Thyroid. 8, 377–383 (1998)PubMedCrossRef R.M. Tuttle, H. Lemar, H.B. Burch, Clinical features associated with an increased risk of thyroid malignancy in patients with follicular neoplasia by fine-needle aspiration. Thyroid. 8, 377–383 (1998)PubMedCrossRef
11.
go back to reference C.R. McHenry, S.R. Thomas, S.J. Slusarczyk, A. Khiyami, Follicular or Hürthle cell neoplasm of the thyroid: can clinical factors be used to predict carcinoma and determine extent of thyroidectomy? Surgery. 126, 798–804 (1999)PubMedCrossRef C.R. McHenry, S.R. Thomas, S.J. Slusarczyk, A. Khiyami, Follicular or Hürthle cell neoplasm of the thyroid: can clinical factors be used to predict carcinoma and determine extent of thyroidectomy? Surgery. 126, 798–804 (1999)PubMedCrossRef
12.
go back to reference W. Raber, K. Kaserer, B. Niederle, H. Vierhapper, Risk factors for malignancy of thyroid nodules initially identified as follicular neoplasia by fine-needle aspiration: results of a prospective study of one hundred twenty patients. Thyroid. 10, 709–712 (2000)PubMedCrossRef W. Raber, K. Kaserer, B. Niederle, H. Vierhapper, Risk factors for malignancy of thyroid nodules initially identified as follicular neoplasia by fine-needle aspiration: results of a prospective study of one hundred twenty patients. Thyroid. 10, 709–712 (2000)PubMedCrossRef
13.
go back to reference Z.W. Baloch, S. Fleisher, V.A. LiVolsi, P.K. Gupta, Diagnosis of “follicular neoplasm”: a gray zone in thyroid fine-needle aspiration cytology. Diagn. Cytopathol. 26, 41–44 (2002)PubMedCrossRef Z.W. Baloch, S. Fleisher, V.A. LiVolsi, P.K. Gupta, Diagnosis of “follicular neoplasm”: a gray zone in thyroid fine-needle aspiration cytology. Diagn. Cytopathol. 26, 41–44 (2002)PubMedCrossRef
14.
go back to reference E.S. Kim, I.S. Nam-Goong, G. Gong, S.J. Hong, W.B. Kim, Y.K. Shong, Postoperative findings and risk for malignancy in thyroid nodules with cytological diagnosis of the so-called “follicular neoplasm”. Korean. J. Intern. Med. 18, 94–97 (2003)PubMed E.S. Kim, I.S. Nam-Goong, G. Gong, S.J. Hong, W.B. Kim, Y.K. Shong, Postoperative findings and risk for malignancy in thyroid nodules with cytological diagnosis of the so-called “follicular neoplasm”. Korean. J. Intern. Med. 18, 94–97 (2003)PubMed
15.
go back to reference T. Giorgadze, E.D. Rossi, G. Fadda, P.K. Gupta, V.A. Livolsi, Z. Baloch, Does the fine-needle aspiration diagnosis of “Hürthle-cell neoplasm/follicular neoplasm with oncocytic features” denote increased risk of malignancy? Diagn. Cytopathol. 31, 307–312 (2004)PubMedCrossRef T. Giorgadze, E.D. Rossi, G. Fadda, P.K. Gupta, V.A. Livolsi, Z. Baloch, Does the fine-needle aspiration diagnosis of “Hürthle-cell neoplasm/follicular neoplasm with oncocytic features” denote increased risk of malignancy? Diagn. Cytopathol. 31, 307–312 (2004)PubMedCrossRef
16.
go back to reference J. Smith, R.E. Cheifetz, N. Schneidereit, K. Berean, T. Thomson, Can cytology accurately predict benign follicular nodules? Am. J. Surg. 189, 592–595 (2005)PubMedCrossRef J. Smith, R.E. Cheifetz, N. Schneidereit, K. Berean, T. Thomson, Can cytology accurately predict benign follicular nodules? Am. J. Surg. 189, 592–595 (2005)PubMedCrossRef
17.
go back to reference R.T. Pu, J. Yang, P.G. Wasserman, T. Bhuiya, K.A. Griffith, C.W. Michael, Does Hurthle cell lesion/neoplasm predict malignancy more than follicular lesion/neoplasm on thyroid fine-needle aspiration? Diagn. Cytopathol. 34, 330–334 (2006)PubMedCrossRef R.T. Pu, J. Yang, P.G. Wasserman, T. Bhuiya, K.A. Griffith, C.W. Michael, Does Hurthle cell lesion/neoplasm predict malignancy more than follicular lesion/neoplasm on thyroid fine-needle aspiration? Diagn. Cytopathol. 34, 330–334 (2006)PubMedCrossRef
18.
go back to reference M. Sahin, A. Gursoy, N.B. Tutuncu, D.N. Guvener, Prevalence and prediction of malignancy in cytologically indeterminate thyroid nodules. Clin. Endocrinol. (Oxf) 65, 514–518 (2006)CrossRef M. Sahin, A. Gursoy, N.B. Tutuncu, D.N. Guvener, Prevalence and prediction of malignancy in cytologically indeterminate thyroid nodules. Clin. Endocrinol. (Oxf) 65, 514–518 (2006)CrossRef
19.
go back to reference T. Rago, G. Di Coscio, F. Basolo, M. Scutari, R. Elisei, P. Berti, P. Miccoli, R. Romani, P. Faviana, A. Pinchera, P. Vitti, Combined clinical, thyroid ultrasound and cytological features help to predict thyroid malignancy in follicular and Hürthle cell thyroid lesions: results from a series of 505 consecutive patients. Clin. Endocrinol. (Oxf) 66, 13–20 (2007) T. Rago, G. Di Coscio, F. Basolo, M. Scutari, R. Elisei, P. Berti, P. Miccoli, R. Romani, P. Faviana, A. Pinchera, P. Vitti, Combined clinical, thyroid ultrasound and cytological features help to predict thyroid malignancy in follicular and Hürthle cell thyroid lesions: results from a series of 505 consecutive patients. Clin. Endocrinol. (Oxf) 66, 13–20 (2007)
20.
go back to reference J.C. Paramo, T. Mesko, Age, tumor size, and in-office ultrasonography are predictive parameters of malignancy in follicular neoplasms of the thyroid. Endocr. Pract. 14, 447–451 (2008)PubMedCrossRef J.C. Paramo, T. Mesko, Age, tumor size, and in-office ultrasonography are predictive parameters of malignancy in follicular neoplasms of the thyroid. Endocr. Pract. 14, 447–451 (2008)PubMedCrossRef
21.
go back to reference P. Trimboli, S. Ulisse, M. D’Alò, F. Solari, A. Fumarola, M. Ruggieri, E. De Antoni, A. Catania, S. Sorrenti, F. Nardi, M. D’Armiento, Analysis of clinical, ultrasound and colour flow-Doppler characteristics in predictingmalignancy in follicularthyroidneoplasms. Clin. Endocrinol. (Oxf) 69, 342–344 (2008)CrossRef P. Trimboli, S. Ulisse, M. D’Alò, F. Solari, A. Fumarola, M. Ruggieri, E. De Antoni, A. Catania, S. Sorrenti, F. Nardi, M. D’Armiento, Analysis of clinical, ultrasound and colour flow-Doppler characteristics in predictingmalignancy in follicularthyroidneoplasms. Clin. Endocrinol. (Oxf) 69, 342–344 (2008)CrossRef
22.
go back to reference N.E. Gulcelik, M.A. Gulcelik, B. Kuru, Risk of malignancy in patients with follicular neoplasm: predictive value of clinical and ultrasonographic features. Arch. Otolaryngol. Head Neck Surg. 134, 1312–1315 (2008)PubMedCrossRef N.E. Gulcelik, M.A. Gulcelik, B. Kuru, Risk of malignancy in patients with follicular neoplasm: predictive value of clinical and ultrasonographic features. Arch. Otolaryngol. Head Neck Surg. 134, 1312–1315 (2008)PubMedCrossRef
23.
go back to reference R. Mihai, A.J. Parker, D. Roskell, G.P. Sadler, One in four patients with follicular thyroid cytology (THY3) has a thyroid carcinoma. Thyroid. 19, 33–37 (2009)PubMedCrossRef R. Mihai, A.J. Parker, D. Roskell, G.P. Sadler, One in four patients with follicular thyroid cytology (THY3) has a thyroid carcinoma. Thyroid. 19, 33–37 (2009)PubMedCrossRef
24.
go back to reference S. Sorrenti, P. Trimboli, A. Catania, S. Ulisse, E. De Antoni, M. D’Armiento, Comparison of malignancy rate in thyroid nodules with cytology of indeterminate follicular or indeterminate Hürthle cell neoplasm. Thyroid. 19, 355–360 (2009)PubMedCrossRef S. Sorrenti, P. Trimboli, A. Catania, S. Ulisse, E. De Antoni, M. D’Armiento, Comparison of malignancy rate in thyroid nodules with cytology of indeterminate follicular or indeterminate Hürthle cell neoplasm. Thyroid. 19, 355–360 (2009)PubMedCrossRef
25.
go back to reference C.C. Lubitz, W.C. Faquin, J. Yang, M. Mekel, R.D. Gaz, S. Parangi, G.W. Randolph, R.A. Hodin, A.E. Stephen, Clinical and cytological features predictive of malignancy in thyroid follicular neoplasms. Thyroid. 20, 25–31 (2010)PubMedCrossRef C.C. Lubitz, W.C. Faquin, J. Yang, M. Mekel, R.D. Gaz, S. Parangi, G.W. Randolph, R.A. Hodin, A.E. Stephen, Clinical and cytological features predictive of malignancy in thyroid follicular neoplasms. Thyroid. 20, 25–31 (2010)PubMedCrossRef
26.
go back to reference R. Asari, B.E. Niederle, C. Scheuba, P. Riss, O. Koperek, K. Kaserer, B. Niederle, Indeterminate thyroid nodules: a challenge for the surgical strategy. Surgery. 148, 516–525 (2010)PubMedCrossRef R. Asari, B.E. Niederle, C. Scheuba, P. Riss, O. Koperek, K. Kaserer, B. Niederle, Indeterminate thyroid nodules: a challenge for the surgical strategy. Surgery. 148, 516–525 (2010)PubMedCrossRef
27.
go back to reference R.T. Schlinkert, J.A. van Heerden, J.R. Goellner, H. Gharib, S.L. Smith, R.F. Rosales, A.L. Weaver, Factors that predict malignant thyroid lesion when fine needle aspiration is suspicious for follicular neoplasm. Mayo. Clinics. Proc. 72, 913–916 (1997)CrossRef R.T. Schlinkert, J.A. van Heerden, J.R. Goellner, H. Gharib, S.L. Smith, R.F. Rosales, A.L. Weaver, Factors that predict malignant thyroid lesion when fine needle aspiration is suspicious for follicular neoplasm. Mayo. Clinics. Proc. 72, 913–916 (1997)CrossRef
28.
go back to reference Z.W. Baloch, S. Fleisher, V.A. LiVolsi, P.K. Gupta, Diagnosis of follicular neoplasm: a gray zone in thyroid fine-needle aspiration cytology. Diagn. Cytopathol. 26, 41–44 (2001)CrossRef Z.W. Baloch, S. Fleisher, V.A. LiVolsi, P.K. Gupta, Diagnosis of follicular neoplasm: a gray zone in thyroid fine-needle aspiration cytology. Diagn. Cytopathol. 26, 41–44 (2001)CrossRef
29.
go back to reference N.D. Banks, J. Kowalski, H.L. Tsai, H. Somervell, R. Tufano, A.P. Dackiw, M.R. Marohn, D.P. Clark, C.B. Umbricht, M.A. Zeiger, A diagnostic predictor model for indeterminate or suspicious thyroid FNA samples. Thyroid. 18, 933–941 (2008)PubMedCrossRef N.D. Banks, J. Kowalski, H.L. Tsai, H. Somervell, R. Tufano, A.P. Dackiw, M.R. Marohn, D.P. Clark, C.B. Umbricht, M.A. Zeiger, A diagnostic predictor model for indeterminate or suspicious thyroid FNA samples. Thyroid. 18, 933–941 (2008)PubMedCrossRef
30.
go back to reference M.L. Carcangiu, S. Bianchi, D. Savino, I.M. Voynick, J. Rosai, Follicular Hurthle cell tumors of the thyroid. Cancer. 68, 1944–1953 (1991)PubMedCrossRef M.L. Carcangiu, S. Bianchi, D. Savino, I.M. Voynick, J. Rosai, Follicular Hurthle cell tumors of the thyroid. Cancer. 68, 1944–1953 (1991)PubMedCrossRef
31.
go back to reference G. Bahar, D. Braslavsky, T. Shpitzer, R. Feinmesser, S. Avidan, A. Popovtzer, S. Karl, The cytological and clinical value of the thyroid follicular lesion. Am. J. Otolaryngol. 24, 217–220 (2003)PubMedCrossRef G. Bahar, D. Braslavsky, T. Shpitzer, R. Feinmesser, S. Avidan, A. Popovtzer, S. Karl, The cytological and clinical value of the thyroid follicular lesion. Am. J. Otolaryngol. 24, 217–220 (2003)PubMedCrossRef
32.
go back to reference T. Rago, M. Scutari, F. Santini, V. Loiacono, P. Piaggi, G. Di Coscio, F. Basolo, P. Berti, A. Pinchera, P. Vitti, Real-time elastosonography: usefultool for refining the presurgicaldiagnosis in thyroid nodules withindeterminate or nondiagnosticcytology. J. Clin. Endocrinol. Metab. 95, 5274–5280 (2010)PubMedCrossRef T. Rago, M. Scutari, F. Santini, V. Loiacono, P. Piaggi, G. Di Coscio, F. Basolo, P. Berti, A. Pinchera, P. Vitti, Real-time elastosonography: usefultool for refining the presurgicaldiagnosis in thyroid nodules withindeterminate or nondiagnosticcytology. J. Clin. Endocrinol. Metab. 95, 5274–5280 (2010)PubMedCrossRef
33.
go back to reference P.V. Lippolis, S. Tognini, G. Materazzi, A. Polini, R. Mancini, C.E. Ambrosini, A. Dardano, F. Basolo, M. Seccia, P. Miccoli, F. Monzani, Is elastography actually useful in the presurgicalselection of thyroid nodules withindeterminatecytology? J. Clin. Endocrinol. Metab. 96, E1826–E1830 (2011)PubMedCrossRef P.V. Lippolis, S. Tognini, G. Materazzi, A. Polini, R. Mancini, C.E. Ambrosini, A. Dardano, F. Basolo, M. Seccia, P. Miccoli, F. Monzani, Is elastography actually useful in the presurgicalselection of thyroid nodules withindeterminatecytology? J. Clin. Endocrinol. Metab. 96, E1826–E1830 (2011)PubMedCrossRef
34.
go back to reference U. Unlütürk, M.F. Erdogan, O. Demir, S. Güllü, N. Başkal, Ultrasound-elastography is not superior to gray-scale ultrasound in predicting malignancy in thyroid nodules. Thyroid. 22, 1031–1038 (2012)PubMedCrossRef U. Unlütürk, M.F. Erdogan, O. Demir, S. Güllü, N. Başkal, Ultrasound-elastography is not superior to gray-scale ultrasound in predicting malignancy in thyroid nodules. Thyroid. 22, 1031–1038 (2012)PubMedCrossRef
35.
go back to reference D. Vriens, J.H. de Wilt, G.J. van der Wilt, R.T. Netea-Maier, W.J. Oyen, L.F. de Geus-Oei, The role of [18F]-2-fluoro-2-deoxy-d-glucose-positron emission tomography in thyroid nodules with indeterminate fine-needle aspiration biopsy: systematic review and meta-analysis of the literature. Cancer. 117, 4582–4594 (2011)PubMedCrossRef D. Vriens, J.H. de Wilt, G.J. van der Wilt, R.T. Netea-Maier, W.J. Oyen, L.F. de Geus-Oei, The role of [18F]-2-fluoro-2-deoxy-d-glucose-positron emission tomography in thyroid nodules with indeterminate fine-needle aspiration biopsy: systematic review and meta-analysis of the literature. Cancer. 117, 4582–4594 (2011)PubMedCrossRef
36.
go back to reference D. Deandreis, A. Al Ghuzlan, A. Auperin, P. Vielh, B. Caillou, L. Chami, J. Lumbroso, J.P. Travagli, D. Hartl, E. Baudin, M. Schlumberger, S. Leboulleux, Is (18)F-fluorodeoxyglucose-PET/CT useful for the presurgical characterization ofthyroid nodules with indeterminate fine needle aspiration cytology? Thyroid. 22, 165–172 (2012)PubMedCrossRef D. Deandreis, A. Al Ghuzlan, A. Auperin, P. Vielh, B. Caillou, L. Chami, J. Lumbroso, J.P. Travagli, D. Hartl, E. Baudin, M. Schlumberger, S. Leboulleux, Is (18)F-fluorodeoxyglucose-PET/CT useful for the presurgical characterization ofthyroid nodules with indeterminate fine needle aspiration cytology? Thyroid. 22, 165–172 (2012)PubMedCrossRef
37.
go back to reference G. Treglia, B. Muoio, L. Giovanella, M. Salvatori, The role of positron emissiontomography and positron emission tomography/computed tomography in thyroid tumours: an overview. Eur. Arch. Otorhinolaryngol. 270, 1783–1787 (2013)PubMedCrossRef G. Treglia, B. Muoio, L. Giovanella, M. Salvatori, The role of positron emissiontomography and positron emission tomography/computed tomography in thyroid tumours: an overview. Eur. Arch. Otorhinolaryngol. 270, 1783–1787 (2013)PubMedCrossRef
38.
go back to reference E. Saggiorato, T. Angusti, R. Rosas, M. Martinese, M. Finessi, F. Arecco, E. Trevisiol, N. Bergero, B. Puligheddu, M. Volante, V. Podio, M. Papotti, F. Orlandi, 99 mTc-MIBI imaging in the presurgical characterization of thyroid follicular neoplasms: relationship to multidrug resistance protein expression. J. Nucl. Med. 50, 1785–1793 (2009)PubMedCrossRef E. Saggiorato, T. Angusti, R. Rosas, M. Martinese, M. Finessi, F. Arecco, E. Trevisiol, N. Bergero, B. Puligheddu, M. Volante, V. Podio, M. Papotti, F. Orlandi, 99 mTc-MIBI imaging in the presurgical characterization of thyroid follicular neoplasms: relationship to multidrug resistance protein expression. J. Nucl. Med. 50, 1785–1793 (2009)PubMedCrossRef
39.
go back to reference L.M. Hurtado-López, S. Arellano-Montaño, E.M. Torres-Acosta, F.R. Zaldivar-Ramirez, R.M. Duarte-Torres, P. Alonso-De-Ruiz, I. Martínez-Duncker, C. Martínez-Duncker, Combined use of fine-needle aspiration biopsy, MIBI scans and frozen section biopsy offers the best diagnostic accuracy in the assessment of the hypofunctioning solitary thyroid nodule. Eur. J. Nucl. Med. Mol. Imaging. 31, 1273–1279 (2004)PubMedCrossRef L.M. Hurtado-López, S. Arellano-Montaño, E.M. Torres-Acosta, F.R. Zaldivar-Ramirez, R.M. Duarte-Torres, P. Alonso-De-Ruiz, I. Martínez-Duncker, C. Martínez-Duncker, Combined use of fine-needle aspiration biopsy, MIBI scans and frozen section biopsy offers the best diagnostic accuracy in the assessment of the hypofunctioning solitary thyroid nodule. Eur. J. Nucl. Med. Mol. Imaging. 31, 1273–1279 (2004)PubMedCrossRef
40.
go back to reference R. Sharma, A. Mondal, L.R. Shankar, M. Sahoo, P. Bhatnagar, K. Sawroop, M.K. Chopra, R. Kashyap, Differentiation of malignant and benign solitary thyroid nodules using 30- and 120-minute tc-99 m MIBI scans. Clin. Nucl. Med. 29, 534–537 (2004)PubMedCrossRef R. Sharma, A. Mondal, L.R. Shankar, M. Sahoo, P. Bhatnagar, K. Sawroop, M.K. Chopra, R. Kashyap, Differentiation of malignant and benign solitary thyroid nodules using 30- and 120-minute tc-99 m MIBI scans. Clin. Nucl. Med. 29, 534–537 (2004)PubMedCrossRef
41.
go back to reference G. Treglia, C. Caldarella, E. Saggiorato, L. Ceriani, F. Orlandi, M. Salvatori, L. Giovanella, Diagnostic performance of (99 m)Tc-MIBI scan in predicting the malignancy of thyroid nodules: a meta-analysis. Endocrine. 44, 70–78 (2013)PubMedCrossRef G. Treglia, C. Caldarella, E. Saggiorato, L. Ceriani, F. Orlandi, M. Salvatori, L. Giovanella, Diagnostic performance of (99 m)Tc-MIBI scan in predicting the malignancy of thyroid nodules: a meta-analysis. Endocrine. 44, 70–78 (2013)PubMedCrossRef
42.
go back to reference Y.E. Nikiforov, L. Yip, M.N. Nikiforova, New strategies in diagnosing cancer in thyroid nodules: impact of molecular markers. Clin. Cancer. Res. 19, 2283–2288 (2013)PubMedCrossRef Y.E. Nikiforov, L. Yip, M.N. Nikiforova, New strategies in diagnosing cancer in thyroid nodules: impact of molecular markers. Clin. Cancer. Res. 19, 2283–2288 (2013)PubMedCrossRef
43.
go back to reference G. Salvatore, R. Giannini, P. Faviana, A. Caleo, I. Migliaccio, J.A. Fagin, Y.E. Nikiforov, G. Troncone, L. Palombini, F. Basolo, M. Santoro, Analysis of BRAF point mutation and RET/PTC rearrangement refines the fine-needle aspiration diagnosis of papillary thyroid carcinoma. J. Clin. Endocrinol. Metab. 89, 5175–5180 (2004)PubMedCrossRef G. Salvatore, R. Giannini, P. Faviana, A. Caleo, I. Migliaccio, J.A. Fagin, Y.E. Nikiforov, G. Troncone, L. Palombini, F. Basolo, M. Santoro, Analysis of BRAF point mutation and RET/PTC rearrangement refines the fine-needle aspiration diagnosis of papillary thyroid carcinoma. J. Clin. Endocrinol. Metab. 89, 5175–5180 (2004)PubMedCrossRef
44.
go back to reference M.N. Nikiforova, G.C. Tseng, D. Steward, D. Diorio, Y.E. Nikiforov, MicroRNA expression profiling of thyroid tumors: biological significance and diagnostic utility. J. Clin. Endocrinol. Metab. 93, 1600–1608 (2008)PubMedCrossRefPubMedCentral M.N. Nikiforova, G.C. Tseng, D. Steward, D. Diorio, Y.E. Nikiforov, MicroRNA expression profiling of thyroid tumors: biological significance and diagnostic utility. J. Clin. Endocrinol. Metab. 93, 1600–1608 (2008)PubMedCrossRefPubMedCentral
45.
go back to reference E. Saggiorato, R. De Pompa, M. Volante, S. Cappia, F. Arecco, A.P. Dei Tos, F. Orlandi, M. Papotti, Characterization of thyroid ‘follicular neoplasms’ in fine-needle aspiration cytological specimens using a panel of immunohistochemical markers: a proposal for clinical application. Endocr. Relat. Cancer 12, 305–317 (2005)PubMedCrossRef E. Saggiorato, R. De Pompa, M. Volante, S. Cappia, F. Arecco, A.P. Dei Tos, F. Orlandi, M. Papotti, Characterization of thyroid ‘follicular neoplasms’ in fine-needle aspiration cytological specimens using a panel of immunohistochemical markers: a proposal for clinical application. Endocr. Relat. Cancer 12, 305–317 (2005)PubMedCrossRef
46.
go back to reference Y.Y. Liu, H. Morreau, J. Kievit, J.A. Romijn, N. Carrasco, J.W. Smit, Combined immunostaining with galectin-3, fibronectin-1, CITED-1, Hector Battifora mesothelial-1, cytokeratin-19, peroxisome proliferator-activated receptor-{gamma}, and sodium/iodide symporter antibodies for the differential diagnosis of non-medullary thyroid carcinoma. Eur. J. Endocrinol. 158, 375–384 (2008)PubMedCrossRef Y.Y. Liu, H. Morreau, J. Kievit, J.A. Romijn, N. Carrasco, J.W. Smit, Combined immunostaining with galectin-3, fibronectin-1, CITED-1, Hector Battifora mesothelial-1, cytokeratin-19, peroxisome proliferator-activated receptor-{gamma}, and sodium/iodide symporter antibodies for the differential diagnosis of non-medullary thyroid carcinoma. Eur. J. Endocrinol. 158, 375–384 (2008)PubMedCrossRef
47.
go back to reference K.T. Park, S.H. Ahn, J.H. Mo, Y.J. Park, J. Park, S.I. Choi, S.Y. Park, Role of core needle biopsy and ultrasonographic finding in management of indeterminate thyroid nodules. Head. Neck. 33, 160–165 (2011)PubMedCrossRef K.T. Park, S.H. Ahn, J.H. Mo, Y.J. Park, J. Park, S.I. Choi, S.Y. Park, Role of core needle biopsy and ultrasonographic finding in management of indeterminate thyroid nodules. Head. Neck. 33, 160–165 (2011)PubMedCrossRef
48.
go back to reference D.G. Na, J.H. Kim, J.Y. Sung, J.H. Baek, K.C. Jung, H. Lee, H. Yoo, Core-needle biopsy is more useful than repeat fine-needle aspiration in thyroid nodules read as nondiagnostic or atypia of undetermined significance by the bethesda system for reporting thyroid cytopathology. Thyroid. 22, 468–475 (2012)PubMedCrossRef D.G. Na, J.H. Kim, J.Y. Sung, J.H. Baek, K.C. Jung, H. Lee, H. Yoo, Core-needle biopsy is more useful than repeat fine-needle aspiration in thyroid nodules read as nondiagnostic or atypia of undetermined significance by the bethesda system for reporting thyroid cytopathology. Thyroid. 22, 468–475 (2012)PubMedCrossRef
49.
go back to reference N. Nasrollah, P. Trimboli, L. Guidobaldi, D.D. Cicciarella Modica, C. Ventura, G. Ramacciato, S. Taccogna, F. Romanelli, S. Valabrega, A. Crescenzi, Thin core biopsy should help to discriminate thyroid nodules cytologically classified as indeterminate. A new sampling technique. Endocrine. 43, 659–665 (2013)PubMedCrossRef N. Nasrollah, P. Trimboli, L. Guidobaldi, D.D. Cicciarella Modica, C. Ventura, G. Ramacciato, S. Taccogna, F. Romanelli, S. Valabrega, A. Crescenzi, Thin core biopsy should help to discriminate thyroid nodules cytologically classified as indeterminate. A new sampling technique. Endocrine. 43, 659–665 (2013)PubMedCrossRef
50.
go back to reference American Thyroid Association (ATA) guidelines taskforce on thyroid nodules and differentiated thyroid cancer, D.S. Cooper, G.M. Doherty, B.R. Haugen, R.T. Kloos, S.L. Lee, S.J. Mandel, E.L. Mazzaferri, B. McIver, F. Pacini, M. Schlumberger, S.I. Sherman, D.L. Steward, R.M. Tuttle, Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid. 19, 1167–1214 (2009)PubMedCrossRef American Thyroid Association (ATA) guidelines taskforce on thyroid nodules and differentiated thyroid cancer, D.S. Cooper, G.M. Doherty, B.R. Haugen, R.T. Kloos, S.L. Lee, S.J. Mandel, E.L. Mazzaferri, B. McIver, F. Pacini, M. Schlumberger, S.I. Sherman, D.L. Steward, R.M. Tuttle, Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid. 19, 1167–1214 (2009)PubMedCrossRef
Metadata
Title
Clinical characteristics as predictors of malignancy in patients with indeterminate thyroid cytology: a meta-analysis
Authors
Pierpaolo Trimboli
Giorgio Treglia
Leo Guidobaldi
Enrico Saggiorato
Giuseppe Nigri
Anna Crescenzi
Francesco Romanelli
Fabio Orlandi
Stefano Valabrega
Ramin Sadeghi
Luca Giovanella
Publication date
01-05-2014
Publisher
Springer US
Published in
Endocrine / Issue 1/2014
Print ISSN: 1355-008X
Electronic ISSN: 1559-0100
DOI
https://doi.org/10.1007/s12020-013-0057-1

Other articles of this Issue 1/2014

Endocrine 1/2014 Go to the issue